We are live on
!
Find out more
CBT
Central Bank & Trust Portfolio holdings
AUM
$705M
1-Year Est. Return
34.21%
This Fund
S&P 500
This Quarter
Est. Return
+4.88%
1 Year Est. Return
+34.21%
3 Year Est. Return
+110%
5 Year Est. Return
+142.3%
10 Year Est. Return
+478.86%
AUM
$385M
AUM Growth
-$1.12M
(-0.29%)
Cap. Flow
-$16.6M
Cap. Flow
% of AUM
-4.32%
Top 10 Holdings %
Top 10 Hldgs %
28.74%
Holding
332
New
6
Increased
38
Reduced
139
Closed
59
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Analog Devices
ADI
|
+$5.17M |
| 2 |
S&P Global
SPGI
|
+$4.36M |
| 3 |
Broadcom
AVGO
|
+$3.75M |
| 4 |
Morgan Stanley
MS
|
+$3.45M |
| 5 |
Bank of America
BAC
|
+$3.34M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Paychex
PAYX
|
+$5.13M |
| 2 |
DFS
Discover Financial Services
DFS
|
+$4.42M |
| 3 |
FedEx
FDX
|
+$3.51M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.99M |
| 5 |
Blackstone
BX
|
+$2.43M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.2% |
| 2 | Financials | 12.28% |
| 3 | Healthcare | 10.69% |
| 4 | Industrials | 8.73% |
| 5 | Consumer Discretionary | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN
51
DELISTED
Allergan plc
AGN
| $2.84M | 0.74% |
11,683
-337
| -3% | -$79.2K |
|
52
Vanguard FTSE Pacific ETF
VPL
$8.05B
| $2.72M | 0.71% |
41,318
-2,675
| -6% | -$173K |
|
53
Biogen
BIIB
$29.9B
| $2.64M | 0.69% |
9,734
+156
| +2% | +$41.3K |
|
54
Meta Platforms (Facebook)
META
$1.51T
| $2.54M | 0.66% |
16,822
-169
| -1% | -$25.1K |
|
|
55
FedEx
FDX
$74.5B
| $2.4M | 0.62% |
11,050
-17,788
| -62% | -$3.51M |
|
56
Verizon
VZ
$194B
| $2.34M | 0.61% |
52,383
-9,387
| -15% | -$437K |
|
57
iShares Core S&P Mid-Cap ETF
IJH
$123B
| $2.27M | 0.59% |
65,105
-2,885
| -4% | -$99.6K |
|
58
Salesforce
CRM
$134B
| $2.05M | 0.53% |
23,632
-866
| -4% | -$75.4K |
|
59
Helmerich & Payne
HP
$3.53B
| $1.99M | 0.52% |
36,654
+638
| +2% | +$37.4K |
|
60
Monster Beverage
MNST
$91.4B
| $1.9M | 0.49% |
76,302
+69,846
| +1,082% | +$1.68M |
|
61
Amgen
AMGN
$203B
| $1.87M | 0.49% |
10,851
-327
| -3% | -$53.2K |
|
62
Johnson & Johnson
JNJ
$635B
| $1.87M | 0.48% |
14,103
-1,082
| -7% | -$138K |
|
|
AET
63
DELISTED
Aetna Inc
AET
| $1.73M | 0.45% |
11,361
-850
| -7% | -$120K |
|
64
iShares Core MSCI EAFE ETF
IEFA
$186B
| $1.65M | 0.43% |
27,016
-708
| -3% | -$42.7K |
|
65
Becton Dickinson
BDX
$43.1B
| $1.5M | 0.39% |
7,860
-214
| -3% | -$39.1K |
|
66
iShares Core S&P Small-Cap ETF
IJR
$109B
| $1.5M | 0.39% |
21,345
-2,137
| -9% | -$148K |
|
67
Home Depot
HD
$332B
| $1.5M | 0.39% |
9,749
+243
| +3% | +$37.3K |
|
68
Oracle
ORCL
$331B
| $1.48M | 0.38% |
29,488
-758
| -3% | -$34.5K |
|
69
Matador Resources
MTDR
$6.31B
| $1.43M | 0.37% |
66,820
| – | – |
|
70
Pfizer
PFE
$140B
| $1.36M | 0.35% |
42,815
-3,634
| -8% | -$115K |
|
71
iShares US Energy ETF
IYE
$1.74B
| $1.31M | 0.34% |
36,866
-10,521
| -22% | -$388K |
|
|
HOLX
72
DELISTED
Hologic
HOLX
| $1.2M | 0.31% |
26,378
-374
| -1% | -$16.5K |
|
73
Procter & Gamble
PG
$343B
| $1.2M | 0.31% |
13,723
+173
| +1% | +$15.3K |
|
74
CVS Health
CVS
$137B
| $1.19M | 0.31% |
14,833
-13,709
| -48% | -$1.08M |
|
75
TJX Companies
TJX
$170B
| $1.15M | 0.3% |
31,864
-2,494
| -7% | -$94K |
|
Similar funds
JPMIA
GHCMRT
BCM
IFM
TWM
SSCM
NG
SC
Central Bank & Trust's Q2 2017 Portfolio in Review
As of Q2 2017, Central Bank & Trust held 332 positions worth $385M, down 0.29% from $386M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Central Bank & Trust withdrew a net $16.6M in Q2 2017, closing 59 positions and reducing 139 holdings. Its most notable exit was State Street Financial Select Sector SPDR ETF, an estimated $2.99M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Central Bank & Trust opened a new position in S&P Global worth $4.59M.
- Central Bank & Trust's largest Q2 2017 buy was S&P Global: 31,427 shares worth $4.59M.
- Central Bank & Trust added most to Analog Devices in Q2 2017, an estimated $5.17M increase.
- Central Bank & Trust's biggest Q2 2017 reduction was Paychex, cutting an estimated $5.13M.
- Central Bank & Trust fully exited State Street Financial Select Sector SPDR ETF in Q2 2017, selling an estimated $2.99M.
- Central Bank & Trust's ten largest holdings make up 29% of its $385M portfolio in Q2 2017.
- Central Bank & Trust opened 6 new positions and closed 59 in Q2 2017.
- Central Bank & Trust's portfolio value fell 0.29% quarter-over-quarter to $385M.
Based on Central Bank & Trust's 13F filing for Q2 2017, filed 11 Jul 2017.